Approaches to Standardization and Quality Control of the Active Pharmaceutical Ingredient of the Synthetic Small Interfering Ribonucleic Acid (siRNA) Drug for Treatment of COVID-19
Pharmaceutical Chemistry Journal · 2026-06 · 60 (3) · 179-186
DOI: 10.1007/s11094-026-03559-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Chemistry Journal, online erschienen am 13.10.2026. Verfasst von V. N. Turenko und 6 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Turenko, V. N., Smirnov, V. V., Bagayev, D. E., Evseyev, M. A., Vlasov, A. A., Khodzhava, M. V., & Khaitov, M. R. (2026). Approaches to Standardization and Quality Control of the Active Pharmaceutical Ingredient of the Synthetic Small Interfering Ribonucleic Acid (siRNA) Drug for Treatment of COVID-19. Pharmaceutical Chemistry Journal, 60(3), 179-186. https://doi.org/10.1007/s11094-026-03559-5
Vancouver
Turenko VN, Smirnov VV, Bagayev DE, Evseyev MA, Vlasov AA, Khodzhava MV, et al. Approaches to Standardization and Quality Control of the Active Pharmaceutical Ingredient of the Synthetic Small Interfering Ribonucleic Acid (siRNA) Drug for Treatment of COVID-19. Pharmaceutical Chemistry Journal. 2026;60(3):179-186. doi:10.1007/s11094-026-03559-5
BibTeX
@article{Turenko2026,
author = {Turenko, V. N. and Smirnov, V. V. and Bagayev, D. E. and Evseyev, M. A. and Vlasov, A. A. and Khodzhava, M. V. and Khaitov, M. R.},
title = {Approaches to Standardization and Quality Control of the Active Pharmaceutical Ingredient of the Synthetic Small Interfering Ribonucleic Acid (siRNA) Drug for Treatment of COVID-19},
journal = {Pharmaceutical Chemistry Journal},
year = {2026},
volume = {60},
number = {3},
pages = {179--186},
doi = {10.1007/s11094-026-03559-5}
}
EUVIMED